|
Mar 20
|
15 Countries with the Highest Life Expectancy in Africa
|
|
Mar 20
|
Fusion (FUSN) Up 99% on $2.4B Buyout Offer From AstraZeneca
|
|
Mar 20
|
AstraZeneca (AZN) to Buy Fusion Pharmaceuticals for $2.4B
|
|
Mar 20
|
PRESS DIGEST-British Business - March 20
|
|
Mar 19
|
These Stocks Moved the Most Today: Nvidia, AMD, Super Micro, Fusion Pharmaceuticals, Nordstrom, International Paper, Tesla, and More
|
|
Mar 19
|
Fusion Rockets 99%, As Radiopharmaceuticals Space Sparks On $2 Billion AstraZeneca Takeover
|
|
Mar 19
|
AstraZeneca (AZN) Follows Boehringer, to Cap Inhaler Cost in US
|
|
Feb 10
|
30 Most Valuable Drug Companies in 2024
|
|
Feb 10
|
Got $5,000? These 3 Stocks Are Near Their 52-Week Lows and Are Underrated Buys
|
|
Feb 9
|
AstraZeneca PLC (NASDAQ:AZN) Q4 2023 Earnings Call Transcript
|
|
Feb 9
|
Ionis' (IONS) Eplontersen Gets Fast Track Tag for New Indication
|
|
Feb 9
|
Pharma Stock Roundup: AZN & LLY's Q4 Earnings, NVO, NVS & MRK's M&A Deals
|
|
Feb 8
|
Energy & Utilities Roundup: Market Talk
|
|
Feb 8
|
AstraZeneca Plc (AZN) Q4 2023 Earnings Call Transcript
|
|
Feb 8
|
AstraZeneca Nose Dives On 'Thoroughly Underwhelming' Fourth-Quarter Results
|
|
Feb 8
|
Astrazeneca (AZN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
|
|
Feb 8
|
Car giant Ford to axe 2,700 German jobs
|
|
Feb 8
|
Health Care Roundup: Market Talk
|
|
Feb 8
|
AstraZeneca Shares Drop on Weak Quarterly Report Despite 2024 Growth Guidance
|
|
Feb 8
|
AstraZeneca Stock Slips on Soft Earnings Report as Cancer Drug Sales Disappoint
|